To study the effects of reduced CD4 T cell activity on hepatitis C virus (HCV) genetic heterogeneity, HCV quasi-species complexity and diversification over time were analyzed for 56 human immunodeficiency virus-coinfected patients. Patients were selected retrospectively from the French Seroconverter Cohort (SEROCO) and the French Hemophilia Cohort (HEMOCO) for having stable CD4 cell counts for 3 years. HCV complexity was assessed by single-strand conformation polymorphism analysis of the envelope-coding region (HVR) and the core region at 2 time points 3 years apart. Increased HVR complexity was associated with higher CD4 cell count and HCV genotype 1 infection. Qualitative variation of HVR and core region was not related to CD4 cell count and depended on the initial complexity. Complexity of both regions remained unchanged over 3 years. Among these HCV-HIV-coinfected patients with stable CD4 cell counts, viral genotype and CD4 cell count may have influenced HVR complexity before their inclusion in the study but were not involved in HVR diversification during the 3-year follow-up period.
The quasi-species nature of hepatitis C virus (HCV) affects the entire genome, from the most conserved 5 0 noncoding region [1, 2] to areas of high variability, which exist in the envelopecoding region (HVR) [3] . Quasi species may be implicated in viral persistence, but their selection mechanism is unclear. Sequence heterogeneity may result from the combination of a high error rate of the viral RNA polymerase and an evolutionary adaptation to the host environment. The high variability of the HVR is attributed to its high tolerance to amino acid substitution [4] and to strong selection pressures associated mainly with neutralizing antibodies [5] [6] [7] [8] [9] [10] . Although it has been studied less, cytotoxic T lymphocyte (CTL) selection appears to be an early event [11, 12] , and there is little evidence of ongoing CTL selection in chronically infected immunocompetent patients [10] . The hypothesis of immune selection of HVR variants has been investigated, in part, by comparing mutation rates in immunocompetent and antibody-deficient or human immunodeficiency virus (HIV)-infected patients [10, [13] [14] [15] [16] [17] [18] . Immunosuppression caused by HIV is characterized by reduced CD4 cell counts and impaired CD4 helper function [19] . The nature of HCV quasi species might be affected if HIV-induced immunosuppression lowers the pressure for selecting HCV substitutions. However, numerous biases may have confounded these earlier studies, including differences in the duration of infection and the influence of viral determinants such as genotype and virus load. Furthermore, if many factors affect HCV sequence evolution, it is possible to fail to detect the effect of HIV infection in a limited number of subjects. Viral heterogeneity can be characterized in terms of complexity and diversity. Diversity refers to the average genetic distance between all pairs of variants in the same population [20] . Genetic complexity applies to the virus population size and is defined as the total number of variants within a quasi-species population. Again, most studies suffer from incomplete definition of analyzed parameters, and comparisons are rendered difficult by differences in the applied methods. The aim of the present study was to analyze, by means of a standardized and reproducible single-strand conformation polymorphism (SSCP) technique, HCV quasi-species complexity and diversification over time in HIV-coinfected patients, according to CD4 cell counts, within the core region and HVR, both of which are known to encode B cell and T cell epitopes. RNA extraction and amplification. Viral RNA was extracted from 140 mL of serum by using the QIAmp Viral RNA kit (Qiagen GmbH). Ten microliters of extracted RNA was subjected to reverse transcription and nested polymerase chain reaction (PCR) amplification using Ready-to-Go reverse-transcriptase PCR and PCR beads (Amersham Pharmacia Biotech).
The following outer and inner primers for HVR1 were used [23] : sense, 5 0 -CGC ATG GCG TGG GAC ATG ATG-3 0 and 5 0 -GCT TGG GAT ATG ATG ATG AAC TGG TC-3 0 ; and reverse, 5 0 -GGT GTG GAG GGA GTC ATT GCA GTT-3 0 and 5 0 -TGC CAC CTG CCA TTG GTG TT-3 0 . Inner primers generate a 307-bp product (nt 956-1262), encompassing the C-terminal E1 transmembrane region and the Nterminal hypervariable E2 region. HVR1 (aa 386-412) contains linear B cell epitopes recognized by neutralizing antibodies [6, 24, 25] and a putative HLA-A2 restricted CTL epitope [26] .
The following outer and inner primers for the core region were used: sense, 5 0 -CGC GCG ACT AGG AAG ACT TC-3 0 and 5 0 -AGG AAG ACT TCC GAG CGG TC-3 0 ; and reverse, 5 0 -ATG TAC CCC ATG AGG TCG GC-3 0 and 5 0 -CCG CAC GTA AGG GTA TCG ATG AC-3 0 . The 240-bp product spans aa 10-90 of the core protein and contains several CTL epitopes, as described elsewhere [27] .
SSCP analysis. A standardized SSCP analysis was performed directly on PCR products of E1/E2 and core genes. One-fifth (5 mL) of the amplicons was mixed with 10 mL of denaturing solution (950 mL/L formamide and 400 mg/L bromophenol blue), was heated for 10 min at 95 C, and was chilled on ice. The electrophoretic analysis was carried out with 7 mL of this mixture, using precast polyacrylamide gels (GeneGel Excel 12.5/24; Amersham Pharmacia Biotech) on a GenePhor electrophoresis unit (Amersham Pharmacia Biotech), according to the manufacturer's instructions. The following running conditions were used at 5 C: 600 V, 25 mA, and 15 W. Samples from a given patient were run on the same gel. SSCP analyses were repeated twice for 30 samples from 15 patients. The same patterns were obtained, confirming reproducibility. Patterns were analyzed independently by 2 investigators. For each patient, the number (N) of bands in each of the 2 samples (N 1 and N 2 ) and the number of bands with the same electrophoretic migration in the 2 samples (common bands [N C ]) were recorded. A third reading was performed to resolve discrepancies. Only patterns with comparable amounts of input PCR products were taken into account for statistical analysis. This amount was checked by the intensity of the double-stranded DNA (i.e., the fraction of nondenatured DNA) on the SSCP gel. The total number of visible bands at each time point was assumed to be an index of quasi-species complexity.
HIV and HCV quantification. HIV and HCV loads were quantified by using the noncompetitive PCR-based Cobas Amplicor HIV and HCV Monitor assays (Roche Diagnostics), as specified by the manufacturer.
HCV genotype determination. HCV genotypes were determined by direct sequencing of the 5 0 noncoding region by using the Tru- Table 1 . Epidemiological and virological data, grouped according to CD4 cell count, at the first time point of the study. Multiple linear regression analysis was used to determine the independent contribution of factors associated with genetic complexity. Explanatory variables were those found to be related to genetic complexity in the univariate model. The P value for entry had to be ,.10. Statistical analysis was performed using SAS software (SAS Institute).
Results
Patients' epidemiologic and virologic characterization. CD4 cell count stability was the main selection criterion for the present study. Other host or virus factors with possible influence on HCV genetic complexity are listed in table 1. Most parameters have a similar distribution according to CD4 cell count. Among patients with CD4 cell counts .500 cells/mm 3 , there were more injection drug users than transfusion recipients (P ¼ :004). However, the estimated HCV disease duration was not dependent on CD4 cell count and was similar for transfusion recipients (5:7^2:4 years) and injection drug users (5:8^5:4 years). In addition, repartition of HCV genotypes (genotype 1 vs. all other genotypes) was independent of infection route and CD4 cell counts.
HIV and HCV loads were assessed at both time points. No significant relationship was found between HCV viremia and CD4 cell count, estimated duration of infection, or HCV genotype. As expected, HIV viremia was higher for patients with lower CD4 cell counts (P ¼ :009; table 1), with a Spearman's correlation coefficient of 20.412 (P ¼ :002). No significant change of HCV or HIV viremia was noted 3 years apart: mean variations were +0:09^0:8 and 20:2^0:7 log copies/mL, respectively. At both time points, aminotransferase levels were not associated with host (CD4 cell count and route of infection) or virus (HCV load and genotype) characteristics.
Genetic complexity. Forty-five (80%) patients had analyzable HVR SSCP patterns, and 49 (87%) had analyzable core SSCP patterns at both time points. Negative results of the PCR assay were not associated with a particular genotype or with lower virus load.
Relationship between genetic complexity and host and virus factors. Data regarding genetic complexity and host and virus factors are shown in table 2. At both time points, HVR genetic complexity was higher in patients with higher CD4 cell counts (P ¼ :026 and P ¼ :006, respectively). Spearman's correlation coefficients were 0.38 (P ¼ :01) and 0.37 (P ¼ :01), respectively.
Higher HVR complexity was found among HCV genotype 1-infected patients at both time points. HVR complexity also tended to be higher among injection drug users (P ¼ :08 at the second time point). HCV load, aminotransferase levels, and putative disease duration were not associated with HVR complexity in univariate analysis. The multivariate analysis evidenced the independent contribution of CD4 cell count (P ¼ :04 and P ¼ :002) and genotype (P ¼ :01 and P ¼ :02) on HVR complexity at both time points, whereas the contamination mode did not emerge as an independent factor of genetic complexity. NOTE. Data are mean number of bands on single-strand conformation polymorphism patterns^SD, except where noted. Multiple linear regression analysis was used to determine the independent contribution of the following factors associated with genetic complexity in the univariate model: contamination mode, hepatitis C virus (HCV) genotype, and CD4 cell count (P is shown in parentheses). IDU, injection drug use; NS, not significant.
In contrast to HVR, no significant relationship was found between core complexity and CD4 cell counts or virological or epidemiological parameters.
Evolution of genetic complexity and genetic diversification. Qualitative changes of HVR and core quasi species were assessed with the variables N 1 2 N C and N 2 2 N C , which represent the disappearance and emergence, respectively, of SSCP bands after 3 years of evolution. The ratios (N 1 2 N C ):N 1 and (N 2 2 N C ):N 2 , corresponding to relative changes, also were analyzed. Both types of constructed variables were compared according to CD4 cell count group by use of the Kruskal-Wallis test. The mean number of disappearing bands was 2:7^2:1 for the HVR and 0:6^1 for the core region. The mean number of emerging bands was 2:8^2:1 for the HVR and 0:5^0:9 for the core region. Despite qualitative evolution, no significant quantitative changes accumulated in 3 years for HVR (6.83 .0 vs. 6.9^3.0) and the core region (6:8^2:2 vs. 6:7^2:1; table 2). Qualitative variation for HVR and the core region was not related to CD4 cell count. The data for HVR are shown in table 3. The absolute number of disappearing and appearing bands tended to be higher for patients with higher CD4 cell counts, but this tendency vanished when relative variation was considered. The relation with initial complexity was supported by Spearman's correlation test (r ¼ 0:44 [P ¼ :004] and r ¼ 0:38 [P ¼ :01] for disappearing and emerging bands, respectively).
Discussion

CD4
+ T lymphocytes have important regulatory functions through their Th1/Th2 secretion profiles that support either CTL responses or antibody production. HIV infection thus may serve as a model to study the influence of both humoral and cellular immune deficiency on HCV genetic heterogeneity. HVR quasi-species selection is widely attributed to immune escape [5] [6] [7] [8] , and earlier studies investigated this hypothesis by comparing HVR heterogeneity in immunocompetent and HIVcoinfected patients [13] [14] [15] [16] [17] [18] . The results of these studies support the hypothesis of quasi-species alteration by HIV infection but provide conflicting results. Shortcomings in size and characterization of the studied populations [13] [14] [15] [16] may have hampered their conclusions. To permit valid inferences, the present investigation included 56 HIV-positive patients with known CD4 cell counts, genotype, viremia, and estimations of HCV infection duration. Each of these factors might influence genetic variation.
In this study, we found evidence for a direct relationship between HVR complexity and CD4 cell counts in HIV-HCVcoinfected patients. Because CD4 cell counts may reflect the degree of immunosuppression, this finding may support immunedependent accumulation of HVR quasi species. However, in a context of supposedly stable selection pressure, HVR complexity did not increase with time, which suggests that differences in quasi-species complexity may have been constituted before inclusion in this study. Furthermore, qualitative changes reflecting positive or negative selection of quasi species were not associated with CD4 cell counts but, instead, depended on basal complexity. However, our study was conducted in a selected population of HIV-positive patients with a slow decline of CD4 cell counts. Results may be different for patients with a rapid decline of CD4 cell counts, as suggested elsewhere [28] .
The striking observation of our study was the quantitative stability of HVR quasi species despite qualitative changes and the absence of a relationship between qualitative changes and CD4 cell counts in a steady-state context. In addition, we also observed that HVR complexity was independently related to HCV genotype. Associations between the genetic complexity of HVR1 variants and disease duration, HCV genotype, virus load, or the infection route occasionally have been reported elsewhere [29, 30] . Discrepancies in the literature, together with the present observation, suggest that there are complex relationships between quasi-species heterogeneity and infection features. From the data, we can hypothesize the existence of virus-host interactions that formerly would have determined the observed viral complexity. We have no view of viral complexity and CD4 cell count Table 3 . Qualitative changes of envelope-coding region hepatitis C virus quasi species at 3-year intervals, according to CD4 cell counts. evolution during the first months after HCV seroconversion. However, several studies have highlighted the determinant role of the anti-HCV immune response during the acute phase on the subsequent course of infection [31] . The sequence of infection can thus be critical. Indeed, if HCV is acquired before HIV, one may presume that the initial anti-HCV immune response would be stronger than in the opposite sequence of infection. Higher immune selection pressure would lead to increased HCV complexity. Given that HCV infection is 10-fold more transmissible by needlestick exposure than is HIV infection [32] , injection drug users could have acquired HCV before HIV, whereas patients with hemophilia and patients who received blood transfusions could have been infected simultaneously. Injection drug users thus would exhibit higher HCV complexity. We indeed found a tendency for higher complexity in that population, but this factor did not emerge as being independently associated with HCV complexity in multivariate analysis. Instead, CD4 cell counts were higher among injection drug users, which is most likely associated with shorter duration of HIV infection, whereas HCV disease duration was similar for both contamination modes. During the course of persistent infection, in this context of stable CD4 cell counts, the host's immune status does not appear to be the main evolutionary force within the investigated envelope region. Although important modification of SSCP patterns were observed in the envelope gene, the studied fragment of the core gene remained virtually unchanged over a 3-year period, and no relationship between core complexity and CD4 cell count was evidenced. The stability of the studied core region may be attributed to strong structural constraints that would not tolerate mutations. Indeed, a high degree of both amino acid and nucleotide sequence conservation may be required for optimal translation and virus assembly [33] . A similar finding has been reported in both immunocompetent and antibody-deficient patients, despite CTL recognition of encoded epitopes [10] . Alternatively, HCV interference with T cell functions may be involved. Chronically infected patients show weak proliferative response to HCV antigens, whereas response to other antigens are preserved. This deficiency is heightened by HIV coinfection [34, 35] .
Although HCV RNA levels do not accurately predict the severity of liver disease, several authors have compared HCV RNA levels in HIV-positive and -negative patients. Most of these studies report higher levels of HCV RNA in coinfected patients [36] [37] [38] [39] [40] . The inverse relationship between HCV RNA levels and CD4 cell counts is far less clear [38, 39, 41] . Differences in the studied populations and in the HCV quantification assays may account for these discrepancies. Among the patients in the present study with stable CD4 cell counts, HCV load and CD4 cell count were not associated.
The absence of HIV-negative patients may be considered to be a limitation of our study. However, our purpose was not to compare immunodeficient HIV-positive and immunocompetent HIV-negative individuals. Instead, we tried to assess the effect of "quantifiable" immune pressure on HCV variability in a steadystate context and to address the mechanism of HCV quasi-species selection in this setting. HIV-induced immunosuppression is characterized by reduced CD4 cell counts and impaired CD4 cell functions. However, coinfected patients with normal CD4 cell counts might not respond as HIV-negative subjects, in part because the extent of HIV-HCV interactions is poorly known and may account for HCV variability. In addition, we conducted a longitudinal study, rather than a cross-sectional study [17, 18] , because this is more appropriate to investigate changes in complexity and selection of variants. A possible limitation of the present work may also be the choice of the SSCP technique to investigate HCV genetic heterogeneity. Cloning of PCR fragments followed by sequence analysis of .20 clones [20] is considered to be the reference method for genetic heterogeneity assessment but is too weighty to be applied to large, population-based studies in which SSCP analysis has been more expedient. SSCP analysis performed with highly standardized reagents and materials has proven specificity and sensitivity [9, 29] to reliably assess HCV complexity. For both cloning and SSCP techniques, the number of target molecules in the original sample may be a limiting factor for complexity assessment. In the present study, all samples have been quantified prior to SSCP analysis. Only 10 of 132 samples have been found with ,100,000 HCV RNA copies/mL, irrespective of the CD4 cell counts (data not shown).
In conclusion, among HIV-infected patients with stable CD4 cell counts, it is suggested that immune response, reflected by CD4 cell counts, and viral genotype may influence HVR complexity on the early phase of HCV infection but that immune response may not be involved in HVR diversification during the course of chronic infection. Greater understanding of ongoing interactions between the 2 infecting viruses in HIV-HCV-coinfected patients may provide insight into the mechanisms of HCV persistence and HCV-induced liver disease.
